T1	Participants 66 117	patients with atrial fibrillation or atrial flutter
T2	Participants 229 282	patients in atrial fibrillation and/or atrial flutter
T3	Participants 490 728	32 patients with atrial fibrillation or atrial flutter (mean +/- SD age, 66 +/- 7 years; mean baseline heart rate, 131 +/- 10 beats per minute) after 20 mg or 20 mg followed by 25-mg bolus doses and a 10 and 15 mg/hr infusion for 24 hours
T4	Participants 1151 1192	Thirty of 32 patients maintained response
